19)
Hatanaka, T. et al.£ºNaunyn-Schmiedeberg's Arch. Pharmacol. 386£¨11£©£º1001, 2013£ÛBE-00212£Ý
20)
Hatanaka, T. et al.£ºNaunyn-Schmiedeberg's Arch. Pharmacol. 386£¨3£©£º247, 2013£ÛBE-00144£Ý
ÎÄÏ×ÕˆÇóÏÈ・ÑuÆ·Çéˆó¤ª†–¤¤ºÏ¤ï¤»ÏÈ
Ö÷ÒªÎÄÏפËÓ›Ýd¤ÎÉçÄÚˆó¸æ•ø¤Ë¤Ä¤¤Þ¤·¤Æ¤âÏÂÓ›¤Ë¤´ÕˆÇóϤµ¤¤¡£
*¥¢¥¹¥Æ¥é¥¹ÑuËaÖêʽ»áÉç¡¡¥á¥Ç¥£¥«¥ë¥¤¥ó¥Õ¥©¥á©`¥·¥ç¥ó¥»¥ó¥¿©`
¨“103-8411¡¡–|¾©¶¼ÖÐÑëÇøÈÕ±¾˜ò±¾î®2¶¡Ä¿5·¬1ºÅ
0120-189-371
ÑuÔìØœ‰Ó˜IÕߵȤÎÊÏÃûÓÖ¤ÏÃû³Æ¼°¤ÓסËù
ÑuÔìØœ‰Ó
¥¢¥¹¥Æ¥é¥¹ÑuËaÖêʽ»áÉç
–|¾©¶¼ÖÐÑëÇøÈÕ±¾˜ò±¾î®2¶¡Ä¿5·¬1ºÅ
ÒÔÏÂÊÇ¡°È«ÇòÒ½Ò©¡±Ïêϸ×ÊÁÏ |
|
|